Study leader Fausto J. Rodriguez, M.D., associate professor of pathology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center, says the new study sought to sort out
what makes the more aggressive NF1 - related
tumors genetically different from low
grade tumors and normal, healthy cells.